» Articles » PMID: 39857292

Research Progress on Natural Products That Regulate MiRNAs in the Treatment of Osteosarcoma

Overview
Journal Biology (Basel)
Publisher MDPI
Date 2025 Jan 25
PMID 39857292
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs are small non-coding RNA molecules that play critical roles in the regulation of gene expression and have been closely associated with various diseases, including cancer. These molecules significantly influence the cell cycle of tumor cells and control programmed cell death (apoptosis). Currently, research on miRNAs has become a major focus in developing cancer therapies. Osteosarcoma, a malignant neoplasm predominantly occurring during adolescence and later in life, is characterized by a high propensity for metastasis. This review explores the role of miRNAs in the initiation and progression of cancer, highlighting their potential as predictive biomarkers for disease. It discusses the mechanisms by which natural products modulate miRNA activity to influence apoptosis, ferroptosis, and autophagy in osteosarcoma cells, aiming to identify new strategies for osteosarcoma treatment. Recent studies on how natural products regulate miRNAs to reduce tumor cell resistance to chemotherapy are also reviewed. Furthermore, the review elaborates on how natural products regulate m6A modifications to influence miRNA expression, thereby exerting antitumor effects. In this process, interactions between m6A modifications and miRNAs have been identified, with both jointly influencing tumorigenesis and cancer progression, offering a new perspective in osteosarcoma treatment. These approaches could help uncover novel regulatory mechanisms in osteosarcoma pathways and provide a theoretical foundation for developing new drugs and identifying novel therapeutic targets.

References
1.
Li Y, Bai X . Naringenin induces ferroptosis in osteosarcoma cells through the STAT3-MGST2 signaling pathway. J Bone Oncol. 2025; 50():100657. PMC: 11743371. DOI: 10.1016/j.jbo.2024.100657. View

2.
Haga S, Kanno A, Morita N, Jin S, Matoba K, Ozawa T . Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/Reperfusion-injury. J Surg Res. 2021; 270:124-138. DOI: 10.1016/j.jss.2021.09.008. View

3.
Eaton B, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato D . Osteosarcoma. Pediatr Blood Cancer. 2020; 68 Suppl 2:e28352. DOI: 10.1002/pbc.28352. View

4.
Zhang Q, Wang F, Jia K, Kong L . Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects. Front Pharmacol. 2018; 9:1253. PMC: 6232953. DOI: 10.3389/fphar.2018.01253. View

5.
Zhang T, Xiang F, Li X, Chen Z, Wang J, Guo J . Mechanistic study on ursolic acid inhibiting the growth of colorectal cancer cells through the downregulation of TGF-β3 by miR-140-5p. J Biochem Mol Toxicol. 2023; 38(1):e23581. DOI: 10.1002/jbt.23581. View